Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2014 and updates on immunization

A comparison of immunogenicity and safety of indigenously developed liquid (DTwPHB-Hib) pentavalent combination vaccine (Shan 5) with Easyfive (Liq) and Tritanrix + Hiberix (Lyo) in Indian infants administered according to the EPI schedule

(2014) Raman Rao et al.   Human vaccines & immunotherapeutics

IAP perspectives on measles and rubella elimination strategies

(2014) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Pertussis vaccines: Position paper of Indian Academy of Pediatrics (IAP)

(2013) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Indian Academy of Pediatrics (IAP) recommended immunization schedule for children aged 0 through 18 years — India, 2013 and updates on immunization

(2013) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials

(2013) Zulfiqar A Bhutta et al.   LANCET INFECTIOUS DISEASES

Post-authorization safety surveillance of a liquid pentavalent vaccine in Guatemalan children

(2013) Edwin J. Asturias et al.   VACCINE

A phase III single arm, multicenter, open-label study to assess the immunogenicity and tolerability of a pentavalent DTwP–HepB–Hib vaccine in indian infants

(2013) Adarsh Eregowda et al.   Human Vaccines & Immunotherapeutics

Consensus recommendations on immunization and IAP immunization timetable 2012

(2012) Vipin M. Vashishtha et al.   INDIAN PEDIATRICS

Development and introduction of a ready-to-use pediatric pentavalent vaccine to meet and sustain the needs of developing countries – Quinvaxem®: The first 5 years

(2012) D.A. Schmid et al.   VACCINE

A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants

(2011) Hitt Sharma et al.   VACCINE

Comparative effects of carrier proteins on vaccine-induced immune response

(2011) Markus Knuf et al.   VACCINE

A Dose‐Escalation Safety and Immunogenicity Study of Live Attenuated Oral Rotavirus Vaccine 116E in Infants: A Randomized, Double‐Blind, Placebo‐Controlled Trial

(2009) Nita Bhandari et al.   JOURNAL OF INFECTIOUS DISEASES